CareX and Chemical Diversity Labs announce research agreement
Under the terms of the agreement, Chemical Diversity Labs, Inc. will provide several lead-enriched libraries for CareX's drug discovery targets in the field of metabolic diseases. ICM protein modeling and flexible docking software platform designed by Chemical Diversity's partner MolSoft (San Diego, CA, USA) was used to find potential binders of CareX's targets. Chemical Diversity Labs, Inc. then produced arrays of potential ligands in parallel synthesis and additionally selected likely binding molecules from its world's largest commercial diverse collection of 400,000 small molecules.
Dr. Jurgen Lehmann, CSO of CareX, and Dr. Stanley Lang, VP Chemistry of Chemical Diversity Labs, Inc., were equally excited about the opportunity of joining the possibilities of rational drug design and modern small molecule synthesis with the target knowledge and screening technology of CareX. The new approach of screening a set of maximum diverse compounds as well as several focused libraries on similar targets for an optimized search of the available chemical space for hits was jointly developed by CareX and Chemical Diversity Labs, Inc.
Most read news
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
LAUDA.LIVE by LAUDA
LAUDA.LIVE - The digital platform for your device management
Comprehensive fleet management options for every LAUDA device - with and without IoT connectivity
ZEISS ZEN core by Carl Zeiss
ZEISS ZEN core - Your Software suite for connected microscopy in laboratory and production
The comprehensive solution for imaging, segmentation, data storage and analysis
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
ACD Spectrus Platform by ACD/Labs
Software for Analytical Data Handling in R&D
Standardized Analytical Data Processing & Knowledge Management
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.